Медицинский совет (May 2018)

Botulinum toxin therapy (Incobotulinumtoxin А) in the complex rehabilitation of adolescents with cerebral palsy (clinical case)

  • E. V. Kostenko,
  • L. V. Petrova

DOI
https://doi.org/10.21518/2079-701X-2018-9-40-45
Journal volume & issue
Vol. 0, no. 9
pp. 40 – 45

Abstract

Read online

The article presents clinical cases of patients with cerebral palsy (CP) in adolescence. The possibility of complex rehabilitation with the use of botulinum therapy (Xeomin) to reduce spasticity, improve active and passive movements is shown. Conclusion. The use of InkobotulinumtoxinА (Xeomin) has shown a significant, persistent, long-term effect on reducing spasticity, passive function and walking in adolescent patients with cerebral palsy. The use of the drug in the total dose of 7,8 to 9,1 U/kg body weight was effective and safe.

Keywords